BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734
78797 results:

  • 1. A giant peripheral ossifying fibroma of the maxilla with extreme difficulty in clinical differentiation from malignancy: a case report and review of the literature.
    Takagi R; Mori K; Koike T; Tsuyuguchi S; Kanai K; Watanabe Y; Okano M; Noguchi Y; Tanaka A; Kurihara K; Sato K; Ishizaki K; Hayashi Y; Imanishi Y
    J Med Case Rep; 2024 May; 18(1):220. PubMed ID: 38702820
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors.
    Lou J; Gong B; Li Y; Guo Y; Li L; Wang J; Liu W; You Z; Zhang H; Pan F; Liang B; Yang L; Zhou G
    Front Immunol; 2024; 15():1332303. PubMed ID: 38698843
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China.
    Han X; Jiang X; He J; Zheng G; Xiong Y; Wen Y; Yang Y; He D; Chen Q; Zhao Y; Li Y; Wu W; Cai Z
    Cancer Med; 2024 May; 13(9):e7232. PubMed ID: 38698679
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Three-dimensional printed custom-made modular talus prosthesis in patients with talus malignant tumor resection.
    He X; Lu M; Zou C; Li Z; Gong T; Kenmegne GR; Wang Y; Luo Y; Zhou Y; Min L; Tu C
    J Orthop Surg Res; 2024 May; 19(1):273. PubMed ID: 38698477
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic.
    Klabusay M; Bábková B
    Klin Onkol; 2024; 38(2):134-138. PubMed ID: 38697822
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement.
    Wlodarski MW; Vlachos A; Farrar JE; Da Costa LM; Kattamis A; Dianzani I; Belendez C; Unal S; Tamary H; Pasauliene R; Pospisilova D; de la Fuente J; Iskander D; Wolfe L; Liu JM; Shimamura A; Albrecht K; Lausen B; Bechensteen AG; Tedgard U; Puzik A; Quarello P; Ramenghi U; Bartels M; Hengartner H; Farah RA; Al Saleh M; Hamidieh AA; Yang W; Ito E; Kook H; Ovsyannikova G; Kager L; Gleizes PE; Dalle JH; Strahm B; Niemeyer CM; Lipton JM; Leblanc TM;
    Lancet Haematol; 2024 May; 11(5):e368-e382. PubMed ID: 38697731
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development of Aptamer-DNAzyme based metal-nucleic acid frameworks for gastric cancer therapy.
    Yan J; Bhadane R; Ran M; Ma X; Li Y; Zheng D; Salo-Ahen OMH; Zhang H
    Nat Commun; 2024 May; 15(1):3684. PubMed ID: 38693181
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A watch, wait, and rescan approach for incidental benign-appearing notochordal lesions of the skull base.
    Usher IE; Drosos E; Morsy A; Wadeson A; Laitt R; Abdulla S; Madhavan A; Halliday J; Rutherford S; King AT; Pathmanaban ON
    Neurosurg Focus; 2024 May; 56(5):E2. PubMed ID: 38691870
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Structure-sparing resection for the management of cervical chordomas: a retrospective institutional series.
    Levy AS; Jamshidi AM; Costello MC; Levi AD
    Neurosurg Focus; 2024 May; 56(5):E6. PubMed ID: 38691869
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection.
    Ghaith AK; Nguyen R; El-Hajj VG; Montaser A; De Biase G; Ravindran K; Perez-Vega C; Lee SJ; Dominari A; Battistin U; Suárez-Meade P; Moussalem C; Patel NP; Kalani MA; Clarke MJ; Rose PS; Bydon M; Abode-Iyamah K; Akinduro OO
    Neurosurg Focus; 2024 May; 56(5):E9. PubMed ID: 38691864
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multidisciplinary surgical considerations for en bloc resection of sacral chordoma: review of recent advances and a contemporary single-center series.
    Schroeder C; de Lomba WC; Leary OP; De la Garza Ramos R; Gillette JS; Miner TJ; Woo AS; Fridley JS; Gokaslan ZL; Zadnik Sullivan PL
    Neurosurg Focus; 2024 May; 56(5):E7. PubMed ID: 38691863
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.
    Palavani LB; Borges P; Andreão FF; Borges J; Batista S; Oliveira LB; Ferreira MY; Reis PCA; Pontes J; Negri H; Beer-Furlan A; Krishna C; Bertani R; Rassi MS
    Neurosurg Focus; 2024 May; 56(5):E11. PubMed ID: 38691862
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Supramarginal resection of skull base chordomas: proof of concept and preliminary outcomes.
    Rychen J; Constanzo F; Xu Y; Johnstone TM; Bex A; Rinaldi M; Lee CK; Fernandez-Miranda JC
    Neurosurg Focus; 2024 May; 56(5):E3. PubMed ID: 38691859
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma.
    Hoppe M; Gersey ZC; Muthiah N; Abdallah HM; Plute T; Abou-Al-Shaar H; Wang EW; Snyderman CH; Zenonos GA; Gardner PA
    Neurosurg Focus; 2024 May; 56(5):E16. PubMed ID: 38691858
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A comparison of endoscopic endonasal versus open approaches for skull base chordoma: a comprehensive National cancer Database analysis.
    Soffer JM; Ulloa R; Chen S; Ziltzer RS; Patel VA; Polster SP
    Neurosurg Focus; 2024 May; 56(5):E5. PubMed ID: 38691856
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The burden of skull base chordomas: insights from a meta-analysis of observational studies.
    Fiore G; Porto E; Bertani GA; Marcus HJ; Saladino A; Pradilla G; DiMeco F; Locatelli M
    Neurosurg Focus; 2024 May; 56(5):E13. PubMed ID: 38691853
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome.
    Consiglieri G; Tucci F; De Pellegrin M; Guerrini B; Cattoni A; Risca G; Scarparo S; Sarzana M; Pontesilli S; Mellone R; Gasperini S; Galimberti S; Silvani P; Filisetti C; Darin S; Forni G; Miglietta S; Santi L; Facchini M; Corti A; Fumagalli F; Cicalese MP; Calbi V; Migliavacca M; Barzaghi F; Ferrua F; Gallo V; Recupero S; Canarutto D; Doglio M; Tedesco L; Volpi N; Rovelli A; la Marca G; Valsecchi MG; Zancan S; Ciceri F; Naldini L; Baldoli C; Parini R; Gentner B; Aiuti A; Bernardo ME
    Sci Transl Med; 2024 May; 16(745):eadi8214. PubMed ID: 38691622
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Plant-Based Diets and Disease Progression in Men With Prostate cancer.
    Liu VN; Van Blarigan EL; Zhang L; Graff RE; Loeb S; Langlais CS; Cowan JE; Carroll PR; Chan JM; Kenfield SA
    JAMA Netw Open; 2024 May; 7(5):e249053. PubMed ID: 38691361
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report.
    Zhang Y; Hu M; Guo C; Yang X; Xiang S; Xu H
    Front Endocrinol (Lausanne); 2024; 15():1373794. PubMed ID: 38689735
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Soft Tissue Reconstruction After Sacral Neoplasm Resection: The University of California San Francisco Experience.
    Falade IO; Knox JA; Piper ML; Hoffman WY; Hansen SL
    Ann Plast Surg; 2024 May; 92(5S Suppl 3):S320-S326. PubMed ID: 38689413
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3940.